Albumin ratios and lupus nephritis
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at whether certain blood test ratios (albumin/globulin and platelet/albumin) can help identify or predict lupus nephritis, a kidney problem caused by lupus. It may help doctors better understand and manage kidney involvement in lupus patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of systemic lupus erythematosus (SLE, commonly called lupus) using the 2019 ACR/EULAR criteria.
- You must have lupus nephritis (kidney disease caused by lupus) according to standard medical criteria.
- You must have had a kidney biopsy and basic lab tests done already (your medical records should have these).
- You cannot have chronic liver disease, blood disorders, or cancer that could affect the blood test results.
- You cannot have had a recent infection or acute inflammation.
- You cannot be taking drugs that are harmful to the kidneys but not related to your lupus treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple urine test to see if it can show how active lupus nephritis (kidney inflammation caused by lupus) is. It might help doctors monitor the condition without needing repeated biopsies.
This study looks at two simple blood tests to predict whether people with lupus nephritis (a kidney disease caused by lupus) may need intensive care or have a higher risk of dying in the hospital. It aims to help doctors identify who needs closer monitoring.
This study tests a simple, needle-free method to check for early heart and blood vessel disease in people with lupus nephritis (kidney inflammation from lupus). It uses a formula based on your blood sugar and fat levels to see if you are at higher risk, without needing special scans.
This study looks at how well the kidneys survive over time in people with lupus nephritis. It uses medical records from the past 2–5 years to understand what affects kidney health.
This study looks at whether two blood markers (AGR and PNI) can help track how active lupus is. You may be eligible if you have lupus and are not pregnant or have other serious health conditions.
This study looks at two simple blood tests to see if they can help doctors understand and predict how lupus-related kidney disease (lupus nephritis) is progressing. The goal is to improve monitoring and treatment decisions for people with this condition.
Hear when a new Lupus Nephritis (LN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.